SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹624 Cr | ₹135 Cr | ₹285 Cr | ₹483 Cr | ₹202 Cr |
What is the latest Total Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹624 Cr |
| Mar2025 | ₹135 Cr |
| Mar2024 | ₹285 Cr |
| Mar2023 | ₹483 Cr |
| Mar2022 | ₹202 Cr |
How is Total Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹624 Cr | 361.75 | |
| Mar2025 | ₹135 Cr | -52.55 | |
| Mar2024 | ₹285 Cr | -40.99 | |
| Mar2023 | ₹483 Cr | 139.09 | |
| Mar2022 | ₹202 Cr | - | |
Compare Total Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹10,524.0 Cr | 11.8% | 17.5% | 58.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | 11.8% |
17.5% |
58.4% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses